Indo US Bio-Tech (NSE:INDOUS) Total Equity: ₹925 Mil (As of Mar. 2026)


NSE:INDOUS Indo US Bio-Tech Ltd NSE:INDOUS
69 GF Score
Price ₹87.02
GF Value ₹311.74
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Indo US Bio-Tech Total Equity?

Indo US Bio-Tech NSE:INDOUS -0.91% 69 Total Equity is ₹925 Mil as of Mar. 2026. GuruFocus rates NSE:INDOUS with a GF Score™ of 69/100 and a GF Value™ of ₹311.74 (Possible Value Trap). The stock has 5 warning signs investors should review.

Indo US Bio-Tech's total equity for the quarter that ended in Mar. 2026 was ₹925 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Indo US Bio-Tech Total Equity Historical Data

* Premium members only.

The historical data trend for Indo US Bio-Tech's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo US Bio-Tech Total Equity Chart

Indo US Bio-Tech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 385.08 544.96 627.47 785.19 925.34

Indo US Bio-Tech Quarterly Data
Mar20 Sep20 Mar21 Sep21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 785.19 0.00 866.69 0.00 925.34
NSE:INDOUS
69GF Score
Indo US Bio-Tech Ltd NSE:INDOUS
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo US Bio-Tech Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Indo US Bio-Tech's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=1330.967-405.628
=925

Indo US Bio-Tech's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=1330.967-405.628
=925

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹925 Mil mean?
Indo US Bio-Tech (NSE:INDOUS) has a Total Equity of ₹925 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Indo US Bio-Tech and its competitors.
Is Indo US Bio-Tech's Total Equity too high?
Indo US Bio-Tech's current Total Equity is ₹925 Mil. Overall, Indo US Bio-Tech has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's Total Equity compare to CTVA and CF?
Indo US Bio-Tech's Total Equity of ₹925 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for an Agriculture company?
A good Total Equity depends on the Agriculture industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Indo US Bio-Tech and its competitors. Indo US Bio-Tech's current Total Equity is ₹925 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹311.74, compared to a current price of ₹87.02 — trading 72.1% below its estimated fair value. The current Total Equity is ₹925 Mil. Indo US Bio-Tech's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current Total Equity is ₹925 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?

Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued. The current stock price of ₹87.02 is trading 72.1% below its estimated GF Value™ of ₹311.74. GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.

Key valuation signals for NSE:INDOUS:

  • Total Equity: ₹925 Mil
  • GF Value™: ₹311.74 vs. price of ₹87.02 (72.1% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indo US Bio-Tech Business Description

Other Exchanges 541304:India
Address Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
69GF Score

Get the complete analysis for NSE:INDOUS

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹87.02
Price
₹311.74
GF Value